Last reviewed · How we verify
NCT05256940: MI-SI
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
NA trial testing Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) in Suicide, Attempted in 470 participants. Currently enrolling.
31 March 2026
Quick facts
| Lead sponsor | VA Office of Research and Development |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 470 |
| Start date | 30 November 2022 |
| Primary completion | 31 March 2026 |
| Estimated completion | 29 June 2027 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R)
- Enhanced usual care (EUC)
Conditions studied
- Suicide, Attempted — all drugs for Suicide, Attempted →
- Suicidal Ideation — all drugs for Suicidal Ideation →
Sponsor
VA Office of Research and Development — full company profile →
Who can join
18 and older, any sex, with Suicide, Attempted or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this project is to conduct a randomized control trial with 470 Veterans to examine the impact of a revised version of Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) on risk for suicide attempts and suicidal ideation when compared to high quality usual care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05256940
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicide, Attempted
Currently open trials in the same condition.
- NCT07219355 — Virtual Reality Lethal Means Safety Training · NA · recruiting
- NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
- NCT06151158 — Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings · NA · recruiting
- NCT06474221 — Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters · NA · recruiting
- NCT06248268 — Neuropsychological Patterns of Suicide Ideators and Suicide Attempters · recruiting
Other VA Office of Research and Development trials
Trials by the same sponsor.
- NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care · Phase 1 · not yet recruiting
- NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran · NA · not yet recruiting
- NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness · NA · not yet recruiting
- NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans · NA · not yet recruiting
- NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05256940 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
- Last refreshed: 28 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05256940.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing